ViewRay Inc (VRAY) News

ViewRay® Files Voluntary Chapter 11 Petitions

ViewRay® Files Voluntary Chapter 11 Petitions PR Newswire DENVER, July 17, 2023 Debtor-in-Possession Financing Secured to Support Ongoing...

Form 8-K - Current report

Form 8-K - Current report

Statement of Changes in Beneficial Ownership (4)

FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...

Statement of Changes in Beneficial Ownership (4)

FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...

VA Oklahoma City Healthcare System Chooses ViewRay's MRIdian® MRI-Guided Radiation Therapy System

VA Oklahoma City Healthcare System Chooses ViewRay's MRIdian® MRI-Guided Radiation Therapy System PR Newswire DENVER, June 13, 2023 First cancer...

Specialized Disclosure Report (sd)

UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM SDSPECIALIZED DISCLOSURE REPORTViewRay, Inc.(Exact name of the...

ViewRay's MRIdian® to be Featured at Leading European Radiation Oncology Meeting

ViewRay's MRIdian® to be Featured at Leading European Radiation Oncology Meeting PR Newswire DENVER, May 12, 2023 50 clinical presentations and...

Current Report Filing (8-k)

0001597313FALSE00015973132023-05-102023-05-10UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549_________________________________...

ViewRay Announces First Quarter 2023 Results

ViewRay Announces First Quarter 2023 Results PR Newswire DENVER, May 10, 2023 DENVER, May 10, 2023 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY...

ViewRay Announces Conference Call for First Quarter 2023 Financial Results to be Held After Market on May 10, 2023

ViewRay Announces Conference Call for First Quarter 2023 Financial Results to be Held After Market on May 10, 2023 PR Newswire DENVER, May 9...

Amended Annual Report (10-k/a)

0001597313trueFY202200015973132022-01-012022-12-3100015973132022-06-30iso4217:USD00015973132023-04-10xbrli:share...

ViewRay Hires Adviser to Evaluate Strategic Alternatives

By Will Feuer ViewRay Inc., which makes a radiation-therapy system, said it has hired Goldman Sachs & Co. as a financial adviser to evaluate...

Current Report Filing (8-k)

0001597313FALSE00015973132023-04-132023-04-13UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549_________________________________...

ViewRay Announces Preliminary First Quarter 2023 Results and Updated Fiscal Year 2023 Financial Guidance; Company to Explore Strategic Alternatives to Maximize Shareholder Value

ViewRay Announces Preliminary First Quarter 2023 Results and Updated Fiscal Year 2023 Financial Guidance; Company to Explore Strategic...